Will Lester

University Hospitals Birmingham NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

41h-index8.5kcitations220works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Platelet Disorders and Treatments(49), Advanced Chemical Physics Studies(29), Heparin-Induced Thrombocytopenia and Thrombosis(23), Complement system in diseases(20), Venous Thromboembolism Diagnosis and Management(18)

Publications220 total

Final analysis of the phase 1/2 trial of valoctocogene roxaparvovec for severe hemophilia A
Hämostaseologie·2026
Assay of Efanesoctocog Alfa in 200 Centres: Data From Collaborative NEQAS BC (United Kingdom) and ECAT (Netherlands) Exercise Autumn 2024
Haemophilia·2025Open Access
UKNEQAS Blood Coagulation Factor Nine (FIX) Gene Therapy Supplementary Exercise 2025
Haemophilia·2025
Appropriate Management of Thrombotic Risk in Patients With Primary Immune Thrombocytopenia in the UK: A Modified Delphi Consensus
eJHaem·2025Open Access
Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura
Blood·2025· 2 cited
Laboratory practice on detection of antiphospholipid antibodies: UK NEQAS blood coagulation survey—2024
British Journal of Haematology·2025Open Access
Reporting haemostasis assays in <scp>IU</scp>/<scp>dL</scp>—A recommendation for harmonisation from the British Society for Haematology Haemostasis and Thrombosis Task Force, <scp>UK NEQAS</scp> for Blood Coagulation and the <scp>UK</scp> Haemophilia Centres Doctors Organisation
British Journal of Haematology·2025
Recombinant Adeno-Associated Virus Integration Profiles in Nonhuman Primates and Gene Therapy Participants after Treatment with Valoctocogene Roxaparvovec
Human Gene Therapy·2025· 1 citedOpen Access
Anti‐<scp>PF4</scp> mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both <scp>HIT</scp>‐like and <scp>VITT</scp>‐like characteristics
British Journal of Haematology·2025· 9 citedOpen Access
Alternative Immunosuppression in Acquired Haemophilia A
Haemophilia·2025Open Access
The diagnostic utility of genetic testing in inherited thrombocytopenia: regional multicenter tertiary experience
Research and Practice in Thrombosis and Haemostasis·2025· 1 citedOpen Access
Impact of new medications on the treatment of immune TTP
Blood·2025· 3 cited
887: FULMINANT HEPATIC FAILURE IN THE SETTING OF TOXIC ACETAMINOPHEN AND IRON COINGESTION
Critical Care Medicine·2025· 1 cited
Demystifying autoimmune HIT: what it is, when to test, and how to treat
Hematology·2024Open Access
The Quest for Effective and Well-Tolerated Treatment for Congenital TTP: Half a Century of Experience in the United Kingdom
Blood·2024Open Access
Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia A
Haemophilia·2024· 25 citedOpen Access
The safety and efficacy of using age-adjusted D-dimers in hospitalised patients in a diverse urban centre: a real-world data study
2024Open Access
Sustained good response to rituximab in acquired von Willebrand syndrome
Blood Coagulation & Fibrinolysis·2024· 2 cited
Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology
British Journal of Haematology·2024· 14 citedOpen Access
A British Society for Haematology guideline on the assessment and management of bleeding risk prior to invasive procedures
British Journal of Haematology·2024· 26 citedOpen Access
page 1 of 11Next →

Frequent Co-authors

Marie Scully(9), Michael Laffan(6), Savita Rangarajan(5), Glenn F. Pierce(5), Wing Yen Wong(5), John Pasi(5), Bella Madan(4), Anne Goodeve(4), Andrea M. Guilliatt(4), Mari Thomas(4), Amanda Clark(4), Tina Dutt(4), John‐Paul Westwood(4), Reinhard Schinke(4), Sue Pavord(3), Beverley J. Hunt(3), Nina Mitchell(3), Emily Symington(3), Chris B. Russell(3), Francesco Rodeghiero(3)